Literature DB >> 23371836

C-reactive protein and the biology of disease.

Waliza Ansar1, Shyamasree Ghosh.   

Abstract

The C-reactive protein (CRP) is a plasma protein of hepatic origin, belonging to pentraxin family and forms a major component of any inflammatory reaction. A key component of the innate immunity pathway, the concentration of CRP may rapidly increase to levels more than 1,000-folds above normal values as a consequence to tissue injury or infection. Although functioning as a classical mediator of innate immunity, it functions via interaction of components of both humoral and cellular effector systems of inflammation. Initially considered as an acute-phase marker in tissue injury, infection and inflammation, it now has a distinct status of a disease marker in cardiovascular diseases and is well known of its clinical and pathological significance. The present torrent of studies in a large number of diseases and associated conditions has highly elucidated the role of CRP as a therapeutic and research reagent. In this review, we focus our attention to role of CRP in health and disease. The future prospect of this review lies in the applicability of CRP as a molecule in understanding and monitoring of the biology of disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371836     DOI: 10.1007/s12026-013-8384-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  84 in total

1.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

2.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  C-reactive protein increases C3 deposition on Leishmania donovani promastigotes in human serum.

Authors:  F J Culley; M Thomson; J G Raynes
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

4.  Analysis of the binding of C-reactive protein to histones and chromatin.

Authors:  T W Du Clos; L T Zlock; R L Rubin
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

5.  C-reactive protein and glycemic control in adults with diabetes.

Authors:  Dana E King; Arch G Mainous; Thomas A Buchanan; William S Pearson
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

6.  Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis.

Authors:  Waliza Ansar; Sumi Mukhopadhyay; S K Hasan Habib; Shyamasree Basu; Bibhuti Saha; Asish Kumar Sen; C N Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

7.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.

Authors:  F C de Beer; C R Hind; K M Fox; R M Allan; A Maseri; M B Pepys
Journal:  Br Heart J       Date:  1982-03

8.  Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis.

Authors:  J-F Wu; Y-H Yang; L-C Wang; J-H Lee; E-Y Shen; B-L Chiang
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473

9.  The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.

Authors:  W L Hutchinson; G E Noble; P N Hawkins; M B Pepys
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 10.  The value of C-reactive protein measurement in rheumatoid arthritis.

Authors:  I G Otterness
Journal:  Semin Arthritis Rheum       Date:  1994-10       Impact factor: 5.532

View more
  81 in total

Review 1.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Factors Associated with Multiple Biomarkers of Systemic Inflammation.

Authors:  Sandi L Navarro; Elizabeth D Kantor; Xiaoling Song; Ginger L Milne; Johanna W Lampe; Mario Kratz; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-11       Impact factor: 4.254

3.  A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Authors:  Brenda Vincenzi; Shannon Stock; Christina P C Borba; Sarah M Cleary; Claire E Oppenheim; Liana J Petruzzi; Xiaoduo Fan; Paul M Copeland; Oliver Freudenreich; Corinne Cather; David C Henderson
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

4.  Predicative values of C-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure.

Authors:  Yinjia Wang; Li Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

5.  Early downregulation of acute phase proteins after doxorubicin exposition in patients with breast cancer.

Authors:  Carolina Panis; Luciana Pizzatti; Aedra Carla Bufalo; Ana Cristina Herrera; Vanessa Jacob Victorino; Rubens Cecchini; Eliana Abdelhay
Journal:  Tumour Biol       Date:  2015-10-15

6.  The influence of systemic inflammation on skeletal muscle in physically active elderly women.

Authors:  Britta Wåhlin-Larsson; Gilles Carnac; Fawzi Kadi
Journal:  Age (Dordr)       Date:  2014-10-14

7.  Preoperative oral health care reduces postoperative inflammation and complications in oral cancer patients.

Authors:  Hideo Shigeishi; Kouji Ohta; Shinichi Fujimoto; Takayuki Nakagawa; Kuniko Mizuta; Shigehiro Ono; Hiroshi Shimasue; Yoshiaki Ninomiya; Koichiro Higashikawa; Misato Tada; Fumi Ishida; Gaku Okui; Toshiya Okumura; Akiko Fukui; Kazumi Kubozono; Kazuhiro Yamamoto; Yoko Ishida; Sayaka Seino; Miho Hashikata; Kazuki Sasaki; Takako Naruse; Mohammad Zeshaan Rahman; Ryo Uetsuki; Akiko Nimiya; Megumi Takamoto; Kana Dainobu; Tomoko Tokikazu; Hiromi Nishi; Masaru Sugiyama; Masaaki Takechi
Journal:  Exp Ther Med       Date:  2016-07-19       Impact factor: 2.447

8.  Elevated Values of C-Reactive Protein Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 11,079 Diseased German Travelers Returning from the Tropics and Subtropics.

Authors:  Karl-Heinz Herbinger; Ingrid Hanus; Mirjam Schunk; Marcus Beissner; Frank von Sonnenburg; Thomas Löscher; Gisela Bretzel; Michael Hoelscher; Hans Dieter Nothdurft; Kristina Lydia Huber
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

9.  Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Akira Togawa; Yoshinori Shirai; Noboru Ichiki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.

Authors:  H H Liu; M W Zhang; J B Guo; J Li; L Su
Journal:  Ir J Med Sci       Date:  2016-05-02       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.